S100A8 and S100A9 and their heterocomplex calprotectin (S100A8/A9) are abundant cytosolic constituents in human neutrophils previously shown to possess antifungal activity. This study was designed to investigate mechanisms involved in the modulation of the antifungal properties of S100A8/A9. S100A8, S100A9 and site-directed mutants of both proteins were tested for their antifungal effect against Candida albicans in microplate dilution assays. Whereas S100A8 alone did not inhibit fungal growth, S100A9 by itself had a moderate antifungal effect. Combining both proteins had the strongest effect. Supporting a potential role for oxidation in S100A8/A9, substitution of methionine 63 or 83 of S100A9 resulted in the loss of antifungal activity. Additionally, the substitution to alanine of cysteine 42 of S100A8 also caused a loss of S100A8's ability to enhance S100A9's antifungal effect. Overall, our data indicate that both S100A8 and S100A9 are required for their fully active antifungal effect and that oxidation regulates S100A8/ A9 antifungal activity through mechanisms that remain to be elucidated and evaluated. Finally, together with our previous work describing the oxidationsensitive anti-inflammatory effects of S100A8/A9, we propose that S100A8/A9 exerts an anti-inflammatory activity in healthy state and that conditions associated with oxidative stress activate the antifungal activity of S100A8/A9.
Introduction
Candida albicans is the most common fungal pathogen in humans (Pfaller et al., 1998; Odds, 2000) . Overgrowth or invasion of the host by this commensal organism may initiate diseases ranging from superficial mucosal infections such as oral thrush to life-threatening systemic illness. Serious infections with this opportunistic pathogen are increasingly observed in immunocompromised patients (Berrouane et al., 1999) . The role of innate immunity in control of candidiasis has been extensively studied (Fidel, 2004) .
Neutrophils, key cellular components of the innate immune system, can exert antimicrobial activity by oxidative and nonoxidative mechanisms (Mambula et al., 2000) . The former is characterized by the respiratory burst, a process whereby molecular oxygen is used to produce reactive oxygen species with direct antimicrobial effect. The nonoxidative mechanisms include the production and release of proteins with antimicrobial activity. The most abundant cytoplasmic protein in neutrophils is calprotectin (referred in this manuscript as S100A8/A9). The antimicrobial activity of S100A8/A9 has been confirmed in many pathogenic microorganisms (Steinbakk et al., 1990) , including C. albicans (Murthy et al., 1993) . S100A8/A9, an important component of the innate immune response is a complex of two small, acidic calcium-binding proteins designated as S100A8 and S100A9. S100A8/A9 is produced by neutrophils, monocytes and epithelial cells and it is found in inflammatory exudates and saliva. Epithelial expression of the two S100 proteins is observed in response to stress while myeloid cells constitutively express the S100 proteins.
Its interactions with leukocytes at sites of inflammation and infection are not completely understood.
Other than its antimicrobial activity (Steinbakk et al., 1990) , the immunologically relevant activities of S100A8/A9 include regulation of leukocyte trafficking (Lackmann, 1993; Ryckman et al., 2003; Sroussi et al., 2006 Sroussi et al., , 2007 , the transport of arachidonic acid (Kerkhoff et al., 2001 ) and the induction of NADPH oxidase (Doussiere et al., 2002) . S100A8/A9 and its components are functionally regulated by their quaternary structure (Leukert et al., 2006) , their oxidation (Lackmann, 1993; Sroussi et al., 2006 Sroussi et al., , 2007 and/ or divalent cations binding (Yui et al., 1997) .
A consensus HXXXH domain shared by S100A8 and S100A9 (Korndorfer et al., 2007) allow both proteins to bind divalent cations. The proapoptotic activity of S100A8/ A9 (Ghavami et al., 2004) , its interaction with arachidonic acid (Kerkhoff et al., 1999) and its growth-inhibitory effect in C. albicans are all influenced by divalent metal cations. For instance, zinc has been shown to reverse the fungistatic effect of S100A8/A9 and zinc deprivation may be the mechanism of action of S100A8/A9's fungistatic effect (Murthy et al., 1993; Sohnle et al., 2000) .
While the domain involved in zinc chelation (HXXXH) is present at the carboxyl tail of both S100A8 and S100A9, work carried out by others (Murthy et al., 1993; Sohnle et al., 2000) has shown that both proteins are required for a maximal fungistatic effect. It has been suggested that the formation of tetramers of S100A8 and S100A9 lead to enhanced zinc-binding capacity (Korndorfer et al., 2007) and in fact may be required for S100A8/A9-driven fungistasis. Whether S100A8 and S100A9 possess fungistatic activity independent of each other or not remains unclear. Murthy et al. (1993) have shown that HPLC fractions of native S100A8/A9 containing S100A9 exhibit fungistatic activity, while fractions depleted of S100A9 but enriched for S100A8 lacked fungistatic activity. Conversely, Sohnle et al. (2000) did not detect any fungistatic activity with either protein on their own.
Other than the binding of divalent cations and the formation of higher order heterocomplexes (Leukert et al., 2006) , oxidation has also been shown to functionally regulate immune modulation by S100A8/A9. Data previously published by others (Harrison et al., 1999) and confirmed in our laboratory (Sroussi et al., 2006) indicate that oxidation of an interspecies-conserved residue on S100A8 (cysteine 42) regulates the effect of this protein on leukocyte trafficking. The effect of S100A9 on neutrophil migration also is regulated by oxidation (Sroussi et al., 2007) . Specifically, our previous work has shown that oxidation of interspecies conserved methionine 63 or 83 but not 81 inhibits the fugistactic effect of S100A9 on neutrophils in vitro.
In the present study, the effect of oxidation on the antifungal activity of S100A8/A9 was evaluated. We hypothesized that oxidation regulates the antifungal effect of S100A8/A9 and is required for S100A8/A9 antifungal activity in vitro. First, the antifungal effect of S100A8 and S100A9 alone or in combination was tested. Next, the antifungal effect of S100A8/A9 was examined after the substitution to alanine of methionine 63 or 83 and 61 (on S100A9) and of cysteine 42 (on S100A8). Finally, to test the potential direct effect of the above site-directed substitutions on the quaternary complex of S100A8/A9, we investigated formation of S100A8/A9 heterocomplexes by wild-type (WT) and mutated protein.
Materials and methods
Recombinant proteins: expression, production and purification Expression, production and purification of S100A8, S100A9 and site-directed mutants of both proteins have been described elsewhere (Tugizov et al., 2005; Sroussi et al., 2007) . Briefly, top10F' Escherichia coli cells (Invitrogen, Carlsbad, CA) transfected with the different pGEX2T constructs were used for production of recombinant proteins. Standard glutathione-S-transferase (GST) protocols from Amersham (Amersham, Piscataway, NJ) were followed. Recombinant proteins were cleaved from their GST tag with thrombin (Amersham).
Microdilution plate growth inhibition assays
Candida albicans strain SC5314 was used in all experiments. SC5314 was propagated in YPD or YNB1CSM12% glucose. Growth inhibition of C. albicans by S100A8/A9 or individual S100A8/A9 peptides was assayed in microdilution plates. The assay was adapted from previously published NCCLS methods (Kohler et al., 1997) . RPMI1640 without sodium bicarbonate and with L-glutamine (Invitrogen) was buffered to pH 7.0 with 0.165 M morpholinepropanesulfonic acid, adjusted to a glucose concentration of 2% and prepared as sterile filtered 2 Â solution. One hundred microliters were added to each microdilution well; the assay medium was then diluted to 1 Â by addition of C. albicans cells (1000 cells mL À1 ) and S100 proteins in a combined volume of 100 mL sterile, pyrogen-free H 2 O. Candida cells were inoculated from stationary phase cultures in YNB1CSM12% glucose. Negative controls did not contain proteins or fungal cells. Fungal growth was assayed overnight. Cell counts were determined by reading OD 600 nm after 24 h of growth at 30 1C. To determine the minimal inhibitory concentration (MIC), a dilution series of S100 proteins in water was prepared.
Formation of heterocomplex
One microgram of S100A8, S100A9 or mutant proteins were mixed in phosphate-buffered saline. The protein mixture was heated to 40 1C for 5 min and left to cool at air temperature. The protein mixture was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and stained with coomassie blue stain. Confirmation of the heterocomplex band identity was done by standard Western blot with a monoclonal antibody for S100A8/A9 (27E10 Bachem, Torrance, CA) complex, which recognizes an epitope not found in individual S100 subunits. Immunoprecipitation of the S100A8/A9 heterocomplex was conducted by adding 1 mL of the monoclonal antibody 27E10 to 5 mg each of S100A8 and S100A9 protein, which were incubated together at 4 1C overnight. Precipitation was conducted with protein G plus agarose (Santa Cruz Biotechnology, Santa Cruz, CA) according to the manufacturer's instructions.
Statistical analyses
Single-sample t-tests were calculated to test the S100A8, S100A9 and combined proteins in comparison with the control wells with a set to 0.05 to determine statistical significance.
Results
To address the question whether both components of S100A8/A9 are required to inhibit fungal growth, S100A8, S100A9 and both proteins in combination were tested in a microdilution plate assay. Neither S100A8 nor S100A9 significantly inhibited fungal growth at concentrations o 100 mg mL À1 (data not shown). At 100 mg mL À1 , S100A9
inhibited fungal growth (t df2 = À 23.019, P o 0.01) while S100A8 alone was inactive at all concentrations tested (Fig. 1) . In contrast, S100A8 and S100A9 together were highly active at inhibiting fungal growth at 10 mg mL
À1
(t df2 = À 62.844, P o 0.001 at 10 mg mL À1 ). Dose response analysis of the antifungal effect of S100A8 and S100A9 added in combination inhibited fungal growth at a concentration of 20 mg mL À1 with an MIC 50 of 6.5 mg mL À1 , as calculated from microplate dilution assays (Fig. 2 ). Next, we tested the hypothesis that oxidation regulated the fungistatic effect of S100A8/A9. Based on our previous work, specific residues previously shown to regulate the Fig. 1 . Inhibition of Candida albicans growth by S100A8, S100A9 and S100A8/A9 complex. Recombinant S100A8, S100A9 and ala 42 S100A8 were added separately and in combination to 96-well plates in order to test their ability to inhibit the growth of C. albicans. The plates were incubated at 30 1C overnight. S100A9 (100 mg mL À1 ) demonstrates growth inhibition whereas the same concentration of S100A8 shows no effect. S100A8 and S100A9 together exert a strong growth inhibition at 10 mg mL
. Ala 42 S100A8 on it own or in combination with S100A9 had no effect on yeast growth. Ã P o 0.01 (single-sample t-test, compared with untreated control). The data are representative of experiments conducted in triplicate a minimum of four times. Fig. 2 . Dose response to the inhibition of Candida albicans growth by S100A8/S100A9. Recombinant S100A8 and S100A9 were added at different concentrations. The dose response curve allowed for the calculation of an MIC 50 of 6.5 mg mL À1 of combined S100A8 and S100A9 proteins.
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S100A8 and S100A9 effect on leukocyte migration were substituted with alanine (Sroussi et al., 2006 (Sroussi et al., , 2007 . First, the cysteine 42 of S100A8 was substituted with alanine. When tested in microdilution assays, ala 42 S100A8 did not enhance the fungistatic effect of S100A9 alone (Fig. 1) so that the substitution of cysteine 42 to alanine abrogated the enhancement of S100A9 fungistatic effect by WTS100A8.
Methionine residues conserved in mouse, rat and human S100A9 at positions 63, 81 and 83 were replaced with alanine. The growth of C. albicans was tested in microdilution plates in the presence of WTS100A8 and different sitedirected mutants of S100A9. Except for the mutant of S100A9 in which methionine 81 was substituted to alanine, all S100A9 mutants displayed a loss of antifungal activity (Fig. 3) . The data showed that substitution to alanine of either methionine 63 or 83 resulted in a significant decrease or in a loss of the antifungal effect (Fig. 3) .
Previous reports have indicated that zinc inhibits the antifungal activity of S100A8/A9 (Sohnle et al., 2000) . We confirmed this finding by testing the effect of zinc chloride (25 mM) on the antifungal activity of WTS100A9 and met 81 S100A9 together with WTS100A8. The data showed (Fig. 4) that both proteins lost their antifungal activity with the addition of zinc chloride.
Finally, we compared the ability of mutant and WT S100A8 and S100A9 to form heterocomplexes. We first found that WTS100A8 and WTS100A9 did not form heteromers after simple mixing of equimolar amounts of the proteins and independently of calcium concentration (data not shown). The two proteins, however, did form heterodimers after a short denaturing heat treatment at 40 1C. The data showed that mutation of methionine residues, which resulted in a loss of antifungal activity, did not affect the ability of the mutated S100A9 protein to form heterodimers with S100A8 (Fig. 5a) . Conversely, substitution of alanine 42 in S100A8 did inhibit the formation of S100A8/S100A9 heterodimers. Identity of the heterodimer of S100A8/A9 was confirmed by Western blot analysis (Fig. 5b) . To confirm the ability of S100A9 mutated protein to form complexes with S100A8, we immunoprecipitated WT and mutated S100A9 mixed 1 : 1 with S100A8 with an antibody previously shown to recognize an epitope formed in the heteromer of S100A8/ A9 not present in S100A8 or S100A9 alone (Hessian & Fisher, 2001) . The data showed that WT and mutated S100A9 could Fig. 3 . Inhibition of Candida albicans growth by S100A8, S100A9 and S100A8/A9 complex. Recombinant S100A8, S100A9 and site-directed mutants of S100A9 were tested for their fungal growth. Ten micrograms mL À1 of S100A8 added to 10 mg mL À1 of WT or mutant S100A9 was tested for their ability to inhibit fungal growth. The data indicate that substitution to alanine of either methionine 63 or 83 results in a loss of antifungal effect whereas substitution of methionine 81 does not result in the same loss of function. Ã P o 0.01 (single-sample t-test, compared with untreated control). Data are representative of experiments conducted in triplicate a minimum of four times. Fig. 4 . Inhibition by zinc chloride of the antifungal effect of S100A8/A9 on Candida albicans. Recombinant S100A8, S100A9 and ala 81 S100A9 were tested in combination in the presence or absence of 25 mM zinc chloride supplementation. Data indicate that the addition of zinc on its own had no effect on fungal growth but that zinc inhibited the observed antifungal effect of WT and ala 81 S100A9 in combination with WTS100A8. Data are representative of experiments conducted in triplicate a minimum of three times. Ã P o 0.01 (single sample t test).
in the presence of S100A8 be precipitated by a S100A8/A9 heterocomplex antibody (Fig. 5c) . S100A8 or S100A9 alone could not be precipitated (data not shown).
Discussion
The present study was undertaken to investigate the molecular mechanisms that regulate the antifungal properties of S100A8/A9 and its constituent proteins. The data indicated that S100A8 has no antifungal affect on its own at the concentrations tested but that S100A9 has an antifungal effect that is further enhanced by S100A8. Therefore, S100A8/A9 is likely regulated by the formation of specific heteromers in which S100A9 would be potentiated by stabilization afforded by S100A8 as has been suggested of the tetramer of S100A8 and S100A9 (Korndorfer et al., 2007) .
Our data indicated that substitution to alanine of either methionine 63 or 83 in S100A9 or cysteine 42 in S100A8 resulted in a loss of antifungal activity. Substitution of methionine 81 did not cause the same functional loss. Our previous work indicated that substitution to alanine of methionine 63 and 83 (but not 81) in S100A9 or cysteine 42 in S100A8 resulted in a fungistactic molecule with decreased functional sensitivity to oxidation. The data presented herein indicate that the same substitutions result in loss of the antifungal effect of S100A8/A9, suggesting a role for oxidation in regulating S100A8/A9's fungal activity.
WTS100A8 and WTS100A9 did not form heterocomplexes unless first denatured by heat. This finding is in accordance with data published by others (Vogl et al., 2006) . Vogl and colleagues have first reported the need for denaturing and renaturing steps for the formation of S100A8/A9 in vitro. This finding is also remarkable because heterocomplex formation in vitro may not reflect accurately the complexity of the regulation of quaternary structure in vivo. Nevertheless, the data we present indicate that ala 42 S100A8 does not form heterocomplexes with S100A9 under conditions in which WTS100A8 would. Deficiency in heterocomplex formation on its own or together with oxidation could explain the non-antifungal phenotype of ala 42-S100A8. Conversely, methionine mutants of S100A9 formed heterocomplexes with S100A8 similar to what was observed with WTS100A9, supporting a direct regulatory function for oxidation of S100A8/A9 antifungal activity. Without knowing which quaternary S100A8/A9 structures are antifungal, it is premature to derive any definitive conclusions from this study of quaternary structure formed by the mutant S100 proteins. The data we present are limited to a crude SDS-PAGE study and it does not exclude the possibility that oxidation of the residues we substituted to alanine affect the formation of active antifungal species of S100A8/A9 (tetramers or others). The position of methionine 63 and 83 in a helices is crucial to the stability of S100A8/A9 tetramers (Korndorfer et al., 2007) . This would indicate that their oxidation may affect the quaternary structure of S100A8/A9. It is remarkable that methionine 83 and not 81, which are both in helix IV of S100A9, affect so differently S100A8/A9's functions. This could be explained by the hydrophobic pocket in which methionine 83 is found (Korndorfer et al., 2007) so that its oxidation may result in a more significant structural alteration. It is evident that further work is needed first to determine which quaternary structure of S100A8/A9 is the active antifungal species and, then, to Fig. 5 . Coomassie stain SDS polyacrylamide gel and Western blot of recombinant S100A8 and S100A9 proteins. (a) S100A8 and S100A9 form monomers and dimers. When together, S100A8 and S100A9 form an additional quaternary structure (lane 3 marked with arrow). Ala 42-S100A8 does not form dimers (lane 4) or heterocomplexes with S100A9 (lane 5). Ala 63 S100A9 and ala 83 S100A9 form heterocomplexes with S100A8 (lanes 7 and 9, respectively) similar to the ones formed by WTS100A9 (lane 3). (b) An antibody that recognizes an epitope present in heterocomplexes of S100A8 and S100A9 demonstrate that WTS100A9, ala 81 S100A9 and ala 83 S100A9 form heterocomplexes of S100A8/A9 when mixed with WTS100A8. (c) Immunoprecipitation of S100A8/S100A9 heterocomplexes with a monoclonal antibody against an epitope formed by the heterocomplex. S100A9 and mutant S100A9 precipitate in the presence of S100A8. Both S100A8 and S100A9 form monomers and dimers as in (a).
assess the effect of oxidation and the above substitutions on the formation of those species.
In summary, the concept of S100A8/A9 as a simple metal chelator with growth-inhibitory activity should be expanded to encompass the complexity and versatility of regulatory mechanisms involving oxidation and quaternary structure formation uncovered in the present studies.
Finally, we propose that in the healthy state, S100A8/A9 subunits would have no antifungal effect. However, conditions associated with oxidative stress, including infection and overgrowth of opportunistic pathogens in sanctuaries such as the oral cavity may activate the antifungal functions of S100A8/A9. Together with our previous work (Sroussi et al., 2006 (Sroussi et al., , 2007 , the data presented in this paper support a model in which S100A8/A9 and its components act either as a chemorepulsive anti-inflammatory agent under reduced conditions or as an antimicrobial proinflammatory agent under oxidative conditions. Tugizov S, Berline J, Herrera R, Penaranda ME, Nakagawa 
